Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BMS Spins Off Mead Johnson In IPO, Retaining Majority Control

This article was originally published in The Tan Sheet

Executive Summary

Bristol-Myers Squibb will spin off its Mead Johnson infants and children nutritional products business in an initial public offering of shares rather than sell the unit, the firm says
Advertisement

Related Content

“Likely” Merck Consumer Health Sale Could Bring $8 Billion – Analysts
“Likely” Merck Consumer Health Sale Could Bring $8 Billion – Analysts
People In Brief
Dutch Firm Vemedia Partners Outside The Box To Thrive During Recession
BMS Divests Indonesian OTC Business, Continues Biopharma Consolidation
Mead Johnson preps for IPO
Wyeth Nutritionals: Pfizer’s New MVP, Or Benchwarmer?
Sales & Earnings In Brief
Bristol-Myers Squibb Weighs Options On Mead Johnson
Bristol-Myers Squibb Weighs Options On Mead Johnson

Topics

Advertisement
UsernamePublicRestriction

Register

PS101582

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel